We recently caught up with Nick Karls, director of compliance at Holmes Murphy and Associates, and Nathan Cassin, pharmacy ...
Statistically significant means there is a very high likelihood the drug impacted its target. But if data are not clinically ...
Buying top dividend stocks and holding them long-term can be a great approach to building your investment portfolio. It boils ...
The Cigna Group (NYSE: NYSE:CI), a leading health services organization, has been navigating a complex landscape of challenges and opportunities in the healthcare sector. Recent analyst reports and ...
For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical conditions that supporters say it does.
In 2016, Perrigo acquired PBM Products for $800 million ... advocating for changes to improve the company’s performance and value. Starboard wanted Perrigo to focus on its core consumer self ...
Performance listed in the above table is net ... driven by differentiated products in electrophysiology and structural heart, in particular, the emerging field of pulsed field ablation (PFA ...
See the 10 stocks » Here are two such dividend stocks that have real potential to deliver optimal performance through ... company's pharmacy benefit manager (PBM), negotiates drug prices with ...
Insurers will continue to grapple with medical costs in excess of reimbursement rates for Medicare Advantage and Medicaid, while commercial coverage also faces continued high medical costs.
My patients have shared with me a newfound mistrust over the safety of all vaccines since the Covid vaccine mandates were forced upon them,” writes a rural public health officer.
The PBM regulatory landscape is rapidly evolving at both federal and state levels, making it critical for our clients involved in the PBM space ...
CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...